Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ANP 1

Next Previous
Search
Drug Profile

ANP 1

Alternative Names: ANP-1; Auditory cell therapy - Lineage Cell Therapeutics; Auditory neuronal cell therapy - Lineage Cell Therapeutics; Auditory neuronal progenitor cell therapy - Lineage Cell Therapeutics; Hearing loss therapeutic - Lineage Cell Therapeutics; ReSonance; ReSonance - Lineage Cell Therapeutics

Latest Information Update: 28 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lineage Cell Therapeutics
  • Developer Lineage Cell Therapeutics; University of Michigan
  • Class Pluripotent stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Hearing loss

Most Recent Events

  • 22 Mar 2023 Lineage has provisional patent application pending for ANP1 program in USA before March 2023
  • 16 Jun 2022 Preclinical trials in Hearing loss in USA (unspecified route) (Lineage Cell Therapeutics pipeline, June 2022)
  • 21 Mar 2022 Lineage Cell Therapeutics files for patent protection for composition and methods of generating auditory neuronal progenitors and methods of treatment for auditory neuropathy in the US

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top